OPPM
ARNA

Opus Point Partners Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Opus Point Partners Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$447K Hold
9,770
– – 0.81% 32
2019
Q2 		$573K Hold
9,770
– – 0.85% 31
2019
Q1 		$438K Buy
+9,770
New +$448K 0.59% 41

Other funds holding ARNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Opus Point Partners Management's ARNA Position: Q3 2019 in Review

Opus Point Partners Management held its Arena Pharmaceuticals Inc (ARNA) position steady in Q3 2019 at 9,770 shares worth $447K. The position accounts for 0.81% of the portfolio, ranked #32.

Opus Point Partners Management first reported a position in ARNA in Q1 2019 and has held it in 3 quarters since. The position peaked at $573K in Q2 2019. 230 funds tracked by Wall St. Rank hold ARNA as of Q3 2019.

  • Opus Point Partners Management held 9,770 shares of Arena Pharmaceuticals Inc worth $447K as of Q3 2019.
  • Opus Point Partners Management left its Arena Pharmaceuticals Inc share count unchanged in Q3 2019.
  • Arena Pharmaceuticals Inc made up 0.81% of Opus Point Partners Management's portfolio in Q3 2019, its #32 holding.
  • Opus Point Partners Management first reported a position in Arena Pharmaceuticals Inc in Q1 2019 and has held it in 3 quarters since.
  • Opus Point Partners Management's Arena Pharmaceuticals Inc position peaked at $573K in Q2 2019.
  • 230 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.